Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
40.5M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$1.2B
-
Value change
-
+$38.7M
-
Put/Call ratio
-
1.97
-
Number of buys
-
53
-
Number of sells
-
-50
-
Price
-
$29.73
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2020
133 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q4 2020.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.5M shares
of 63.6M outstanding shares and own 63.63% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (4.49M shares), PRIMECAP MANAGEMENT CO/CA/ (4.34M shares), RA CAPITAL MANAGEMENT, L.P. (4.18M shares), BlackRock Inc. (2.73M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.72M shares), FEDERATED HERMES, INC. (2.62M shares), BAKER BROS. ADVISORS LP (2.31M shares), WELLINGTON MANAGEMENT GROUP LLP (2.1M shares), and MPM ASSET MANAGEMENT LLC (1.91M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.